Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actions

Thrombosis Research

Volumn 82, Issue 1, 1996, Pages 79-86

  Wanaka, Keiko ^a   Okamoto, Shosuke ^a   Horie, Noboru ^b   Hijikata Okunomiya, Akiko ^c   Okamoto, Utako ^a   Naito, Taketoshi ^a   Ohno, Norio ^a   Bohgaki, Miyako ^d   Tsuda, Yuko ^e   Okada, Yoshio ^e  

^a Kobe Res Projects Thromb H   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Kobe Tokiwa Junior College   (Japan)

^e KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

kinin; plasmin synthetic inhibitor; tumor growth

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTIPLASMIN; KININ; PASI 535; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

AMIDOLYSIS; ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; PRIORITY JOURNAL;

EID: 0029871977     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00053-9     Document Type: Article

References (30)

1. KLENIEWSKI, J. and DONALDSON, V.H. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen. J Lab Clin Med 109, 469-479, 1987.
2. APLIN, J.D. and HUGHES, R.C. Complex carbohydrates of the extracellular matrix structures, interactions and biological roles. Biochim Biophys Acta 694, 375-418, 1982.
3. COLIGAN, J.E. and SLAYTER, H.S. Structure of thrombospondin. J Biol Chem 259, 3944-3948, 1984.
4. WERB, Z., MAINARDI, C.L., VATER, C.A. and HARRIS, E.D.Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 296, 1017-1023, 1977.
5. OTT, U., ODERMATT, E., ENGEL, J., FURTHMAYR, H. and TIMPL, R. Protease resistance and conformation of laminin. Eur J Biochem 123, 63-72, 1982.
6. CASTELLINO, F.J. and POWELL, J.R. Human plasminogen Methds Enzymology 80, 365-378, 1981
7. PETERSON, H.I. Experimental studies on fibrinolysis in growth and spread of tumour. Acta Chir Scan [Suppl] 394, 1-42, 1968
8. MARKUS, G. The role of hemostasis and fibrinolysis in the metastatic spread of cancer. SeminThromb Hemost 10, 61-70, 1984.
9. HAJJAR, K.A. and NACHMAN, R.L. The human endothelial cell plasmin-generating system. In: Hemostasis and Thrombosis: Basic principles and clinical practice, Third edition, edited by Colman, R.W., Hirsh, J., Marder, V.J. and Salzman, E.W. pp.823-836, 1994.
10. OKAMOTO, S. Plasmin and antiplasmin. Their pathologic physiology. Keio J Med 8, 211-217, 1959.
11. OKAMOTO, S. and OKAMOTO, U. Amino-methyl-cyclohexane-carboxylic acid: AMCHA; A new potent inhibitor of the fibrinolysis. Keio J Med 11, 105-115, 1962.
12. AMBRUS, C.M., AMBRUS, J.L., LASSMAN, H.B., and MINK, I.B. Studies on the mechanism of action of inhibitors of the fibrinolysin system. Ann N Y Acad Sci 146, 430-446, 1968.
13. IWAMOTO, M., ABIKO, Y. and SHIMIZU, M. Plasminogen-plasmin system. III. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors. J Biochem 64, 759-767, 1968.
14. OKAMOTO, S., OSHIBA, S., MIHARA, H. and OKAMOTO, U. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action. Ann N Y Acad Sci 146, 414-429, 1968.
15. IWAMOTO, M. Plasminogen-plasmin system. IX. Specific binding of tranexamic acid to plasmin. Thrombos Diathes haemorrh (Stuttg.) 33, 573-585, 1975.
16. MARKUS, G., PRIORE, R.L. and WISSLER, F.C. The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem 254, 1211-1216, 1979.
17. OKAMOTO, S., OKAMOTO, U., OKADA, Y., HIJIKATA-OKUNOMIYA, A., WANAKA, K., HORIE, N. and NAITO, T. Coding, decoding and noise of proteinase: a rational approach to plasmin inhibitors. In: Fundamental and clinical fibrinolysis, edited by Castellino, F.J., Gaffney, P.J., Samama, M.M. and Takada, A., pp.67-82, Excerpta Medica, Amsterdam, 1987.
18. OKADA, Y., TSUDA, Y., TENO, N., WANAKA, K., BOHGAKI, M., HIJIKATA-OKUNOMIYA, A., NAITO, T. and OKAMOTO, S. Synthesis of active center-directed peptide inhibitors of plasmin. Chem Pharm Bull 36, 1289-1297, 1988.
19. TENO, N., WANAKA, K., OKADA, Y., TSUDA, Y., OKAMOTO, U., HIJIKATA-OKUNOMIYA, A., NAITO, T. and OKAMOTO, S. Development of active center-directed inhibitors against plasmin. Chem Pharm Bull 39, 2340-2346, 1991.
20. TENO, N., WANAKA, K., OKADA, Y., TAGUCHI, H., OKAMOTO, S., HIJIKATA-OKUNOMIYA, A. and OKAMOTO, S. Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship. Chem Pharm Bull 41, 1079-1090, 1993.
21. KINJO, K., HIRATA, T., and OKAMOTO, S. Studies on the fibrinolysis in tumor bearing mice. I. Fibrinolytic system, ascites retention and intraperitoneal hemorrhage in tumor bearing mice: Suppressing effect of epsilon aminocaproic acid. Kobe J Med Sci 9, 151-160, 1963
22. FUNAHARA, Y. Studies on the fibrinolysis in tumor bearing mice. IV. Mechanism of ascites retention with special reference to plasmin activity of tumor cell origin. Kobe J Med Sci 11, 79-88, 1965.
23. TANAKA, N., OGAWA, H., KINJO, M., KOHGA, S. and TANAKA, K. Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of lewis lung carcinoma. Br J Cancer 46, 428-435, 1982.
24. ÅSTEDT , B., GLIFBERG, I., MATTSSON, W. and TROPÉ, C. Arrest of growth of ovarian tumor by tranexamic acid. JAMA, 238, 154-155, 1977.
25. VERSTRAETE, M. Clinical application of inhibitors of fibrinolysis. Drugs 29, 236-261, 1985.
26. OWEN, J., FRIEDMAN, K.D., GROSSMAN, B.A., WILKINS, C., BERKE, A.D. and POWERS, E.R. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator. J Clin Invest 79, 1642-1647, 1987.
27. TOPOL, E.J., BELL, W.R. and WEISFELDT, M.L. Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study. Ann Int Med 103, 837-843, 1985.
28. STUMP, D.C., CALIFF, R.M., TOPOL, E.J., SIGMON, K., THORNTON, D., MASEK, R., ANDERSON, L., COLLEN, D. and THE TAMI STUDY GROUP. Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Circulation 80, 1222-1230, 1989.
29. LEW, A.S., LARAMEE, P., CERCEK, B., SHAW, P.K., and GANZ, W. The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction. Circulation 72, 1321-1326, 1985
30. OKAMOTO, S., OKADA, Y., NAITO, T., WANAKA, K., HIJIKATA, A., KATSUURA, Y. and OKAMOTO, U. Quite new series of synthetic plasmin inhibitors characterized by extremely potent fibrinogenolysis inhibition. Thrombos.Haemostas 54, 42, 1985